Bio-Techne Corporation (NASDAQ: TECH), a leading global provider of innovative tools and bioactive reagents for research and clinical diagnostics, has announced a strategic partnership with Leader Life Sciences. Under this agreement, Leader Life Sciences will serve as a distributor for Bio-Techne’s extensive product portfolio across the Gulf Cooperation Council (GCC) countries, which include Bahrain, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
Founded in 2020, Leader Life Sciences is a premier scientific solutions provider dedicated to advancing research and diagnostics in the Middle East and North Africa (MENA) region. The company collaborates with private and public research centers, educational institutions, and healthcare organizations to support scientific innovation. Their expertise spans lab automation, digital pathology, turnkey laboratory projects, diagnostics, and more. Through this partnership, Leader Life Sciences will distribute Bio-Techne’s cutting-edge products, including antibodies, proteins, immunoassay kits, enzymes, small molecules, proteomic analysis instruments, and spatial biology tools, to biopharma companies, laboratories, hospitals, and universities across the GCC region.
“We are excited to partner with Leader Life Sciences to expand the reach of our products and services throughout the GCC countries,” said Dr. Peter Schüßler, Vice President and General Manager of Bio-Techne’s EMEA region. “Leader Life Sciences’ robust distribution network and deep industry knowledge, combined with Bio-Techne’s innovative portfolio, create the perfect synergy to drive scientific and medical advancements in the region.”
Nirmal Kumar, Managing Director of Leader Life Sciences, echoed this enthusiasm: “We are thrilled to collaborate with Bio-Techne, a global leader in life sciences innovation. This partnership represents a significant milestone in our mission to empower researchers, scientists, and diagnosticians in the MENA region. Together, we aim to deliver state-of-the-art technologies that accelerate discovery and advance diagnostics, underscoring our commitment to supporting the scientific community in the region.”
This collaboration underscores both companies’ dedication to fostering scientific progress and improving healthcare outcomes in the GCC region.
